Clinical Trial Update: C1INH Inhibitor Preoperative and Post Kidney Transplant to Prevent DGF & IRI [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating C1 esterase inhibitor given before and after kidney transplant to prevent Delayed graft function and ischemia-reperfusion injury; stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delayed Graft Function
• End-stage Renal Disease
• Ischemia-reperfusion Injury
• Kidney Failure

Drugs mentioned

• C1-esterase inhibitor

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: End Stage Renal Disease, Kidney Failure | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-06-25